LS

Latha Sri Bura

Active Director Director DIN 09772405
DIN 09772405 First appointment Oct 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value •••• Premium profile

About Latha Sri Bura

Data last updated:

Latha Sri Bura is a Director at Libramed Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Libramed Pharmaceuticals Private Limited reported revenue of ₹4.63 Cr (FY 2025).

DIN 09772405
Primary Designation Director
Industry Pharma
First Appointment 21 Oct 2022
Oldest Company Age 7 yrs
Largest company Libramed Pharmaceuticals Private Limited · ₹4.63 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Oct 20222019₹4.63 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Libramed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Latha Sri Bura

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Latha Sri Bura

Latha Sri Bura currently holds 1 directorship: Libramed Pharmaceuticals Private Limited (Director, since 21 Oct 2022, revenue ₹4.63 Cr (FY 2025)).

Latha Sri Bura was first appointed on 21 Oct 2022 as Director at Libramed Pharmaceuticals Private Limited.

The current boards of Latha Sri Bura's companies include Balakrishna Dyavanapelly (Libramed Pharmaceuticals Private Limited), Bharath Gajula (Libramed Pharmaceuticals Private Limited), Mahendhar Punnam (Libramed Pharmaceuticals Private Limited), Pannala Mahipal Reddy (Libramed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available